Other OTC - Delayed Quote USD

Carl Zeiss Meditec AG (CZMWY)

103.78 -1.43 (-1.36%)
At close: May 17 at 3:45 PM EDT
Loading Chart for CZMWY
DELL
  • Previous Close 105.21
  • Open 102.51
  • Bid --
  • Ask --
  • Day's Range 102.51 - 103.91
  • 52 Week Range 77.44 - 134.60
  • Volume 337
  • Avg. Volume 1,093
  • Market Cap (intraday) 9.282B
  • Beta (5Y Monthly) 0.93
  • PE Ratio (TTM) 32.53
  • EPS (TTM) 3.19
  • Earnings Date May 8, 2024
  • Forward Dividend & Yield 1.19 (1.14%)
  • Ex-Dividend Date Mar 22, 2024
  • 1y Target Est --

Carl Zeiss Meditec AG operates as a medical technology company in Germany, rest of Europe, North America, and Asia. It operates in two segments, Ophthalmology and Microsurgery. The Ophthalmology segment offers products and solutions for the diagnosis and treatment of chronic eye diseases, such as ametropia (refraction), cataracts, glaucoma, and renital disorders. This segment also provides devices for general ophthalmological examination and care, including slit lamps, refractometers, tonometers, optical coherence tomography devices, and fundus cameras; and devices for functional diagnostics (perimeters), as well as digital products for storage, evaluation, and sharing of clinical data. In addition, this segment offers surgical ophthalmology products comprising surgical microscopes, biometers, phacoemulsification, and vitrectomy devices; intraocular lenses for cataract patients; and systems and consumables for laser eye surgery. The Microsurgery segment provides products and solutions for invasive surgical treatments; and solutions in the area of ear, nose and throat, plastic and reconstructive, neuro, dental, and spinal surgeries. It serves physicians in various fields and hospitals. The company was founded in 1846 and is headquartered in Jena, Germany. Carl Zeiss Meditec AG is a subsidiary of Carl Zeiss AG.

www.zeiss.com/meditec-ag/de/investor-relations.html?vaURL=www.zeiss.de/meditec-ag/ir

4,950

Full Time Employees

September 30

Fiscal Year Ends

Recent News: CZMWY

Performance Overview: CZMWY

Trailing total returns as of 5/17/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

CZMWY
4.00%
DAX PERFORMANCE-INDEX
11.66%

1-Year Return

CZMWY
13.31%
DAX PERFORMANCE-INDEX
17.65%

3-Year Return

CZMWY
36.67%
DAX PERFORMANCE-INDEX
21.33%

5-Year Return

CZMWY
10.52%
DAX PERFORMANCE-INDEX
51.94%

Compare To: CZMWY

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: CZMWY

Valuation Measures

Annual
As of 5/17/2024
  • Market Cap

    9.26B

  • Enterprise Value

    9.38B

  • Trailing P/E

    32.53

  • Forward P/E

    30.67

  • PEG Ratio (5yr expected)

    3.56

  • Price/Sales (ttm)

    4.12

  • Price/Book (mrq)

    4.07

  • Enterprise Value/Revenue

    4.19

  • Enterprise Value/EBITDA

    18.58

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    12.67%

  • Return on Assets (ttm)

    7.03%

  • Return on Equity (ttm)

    12.83%

  • Revenue (ttm)

    2.06B

  • Net Income Avi to Common (ttm)

    261.22M

  • Diluted EPS (ttm)

    3.19

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    15.34M

  • Total Debt/Equity (mrq)

    6.74%

  • Levered Free Cash Flow (ttm)

    49.06M

Research Analysis: CZMWY

Company Insights: CZMWY

Research Reports: CZMWY

People Also Watch